Suchergebnisse - "De La Rosa, Guy"

PubPharm (35)

1

Phase 1 Trial of the Safety, Pharmacokinetics, and Antiviral Activity of EDP-514 in Untreated Viremic Chronic Hepatitis B Patients

enthalten in: Clinical and molecular hepatology | 2024

von Yuen, M. | Chuang, W. | Peng, C. | +9

2

EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis B

enthalten in: Antiviral therapy | 2022

von Feld, J. | Lawitz, E. | Nguyen, T. | +11

3

Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis : A phase 3 study (OPTIMIST-2)

enthalten in: Hepatology (Baltimore, Md.) | 2016

von Lawitz, E. | Matusow, G. | DeJesus, E. | +17

CommentIn: Hepatology. 2016 Aug;64(2):330-2. - PMID 26992027

4

Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis : OPTIMIST-1, a phase 3, randomized study

enthalten in: Hepatology (Baltimore, Md.) | 2016

von Kwo, P. | Gitlin, N. | Nahass, R. | +15

CommentIn: Hepatology. 2016 Oct;64(4):1385-6. - PMID 26970320

5

Effects of once-daily darunavir/ritonavir versus atazanavir/ritonavir on insulin sensitivity in HIV-infected persons over 48 weeks : results of an exploratory substudy of METABOLIK, a phase 4, randomized trial

enthalten in: HIV clinical trials | 2016

von Overton, E. | Tebas, P. | Coate, B. | +5

6

Effects of once-daily darunavir/ritonavir versus atazanavir/ritonavir on insulin sensitivity in HIV-infected persons over 48 weeks: results of an exploratory substudy of METABOLIK, a phase 4, randomized trial

enthalten in: HIV clinical trials | 2016

von Overton, E. | Tebas, P. | Coate, B. | +5

7

Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST-2)

enthalten in: Hepatology | 2016

von Lawitz, E. | Matusow, G. | DeJesus, E. | +17

8

Simeprevir Plus Sofosbuvir (12 and 8 Weeks) in HCV Genotype 1-Infected Patients Without Cirrhosis: OPTIMIST-1, a Phase 3, Randomized Study

enthalten in: Hepatology | 2016

von Kwo, P. | Gitlin, N. | Nahass, R. | +15

9

Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study

enthalten in: Hepatology | 2016

von Kwo, P. | Gitlin, N. | Nahass, R. | +15

10

Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis : A phase 3 study (OPTIMIST‐2)

enthalten in: Hepatology | 2016

von Lawitz, E. | Matusow, G. | DeJesus, E. | +17